Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties

Abstract Background Human protein kinases, the key players in phosphoryl signal transduction, have been actively investigated as drug targets for complex diseases such as cancer, immune disorders, and Alzheimer’s disease, with more than 60 successful drugs developed in the past 30 years. However, ma...

Full description

Bibliographic Details
Main Authors: Xiang-Yu Lin, Yu-Wei Huang, You-Wei Fan, Yun-Ti Chen, Nikhil Pathak, Yen-Chao Hsu, Jinn-Moon Yang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Bioinformatics
Subjects:
Online Access:https://doi.org/10.1186/s12859-022-04773-0
_version_ 1797744030059069440
author Xiang-Yu Lin
Yu-Wei Huang
You-Wei Fan
Yun-Ti Chen
Nikhil Pathak
Yen-Chao Hsu
Jinn-Moon Yang
author_facet Xiang-Yu Lin
Yu-Wei Huang
You-Wei Fan
Yun-Ti Chen
Nikhil Pathak
Yen-Chao Hsu
Jinn-Moon Yang
author_sort Xiang-Yu Lin
collection DOAJ
description Abstract Background Human protein kinases, the key players in phosphoryl signal transduction, have been actively investigated as drug targets for complex diseases such as cancer, immune disorders, and Alzheimer’s disease, with more than 60 successful drugs developed in the past 30 years. However, many of these single-kinase inhibitors show low efficacy and drug resistance has become an issue. Owing to the occurrence of highly conserved catalytic sites and shared signaling pathways within a kinase family, multi-target kinase inhibitors have attracted attention. Results To design and identify such pan-kinase family inhibitors (PKFIs), we proposed PKFI sets for eight families using 200,000 experimental bioactivity data points and applied a graph convolutional network (GCN) to build classification models. Furthermore, we identified and extracted family-sensitive (only present in a family) pre-moieties (parts of complete moieties) by utilizing a visualized explanation (i.e., where the model focuses on each input) method for deep learning, gradient-weighted class activation mapping (Grad-CAM). Conclusions This study is the first to propose the PKFI sets, and our results point out and validate the power of GCN models in understanding the pre-moieties of PKFIs within and across different kinase families. Moreover, we highlight the discoverability of family-sensitive pre-moieties in PKFI identification and drug design.
first_indexed 2024-03-12T15:03:52Z
format Article
id doaj.art-df07a3ef2fba48bf879af1badd82978c
institution Directory Open Access Journal
issn 1471-2105
language English
last_indexed 2024-03-12T15:03:52Z
publishDate 2022-06-01
publisher BMC
record_format Article
series BMC Bioinformatics
spelling doaj.art-df07a3ef2fba48bf879af1badd82978c2023-08-13T11:24:52ZengBMCBMC Bioinformatics1471-21052022-06-0123S411310.1186/s12859-022-04773-0Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moietiesXiang-Yu Lin0Yu-Wei Huang1You-Wei Fan2Yun-Ti Chen3Nikhil Pathak4Yen-Chao Hsu5Jinn-Moon Yang6Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung UniversityInstitute of Biomedical Engineering, National Yang Ming Chiao Tung UniversityInstitute of Molecular Medicine and Bioengineering, National Yang Ming Chiao Tung UniversityInstitute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung UniversityInstitute of Bioinformatics and Structural Biology, National Tsing Hua UniversityInstitute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung UniversityInstitute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung UniversityAbstract Background Human protein kinases, the key players in phosphoryl signal transduction, have been actively investigated as drug targets for complex diseases such as cancer, immune disorders, and Alzheimer’s disease, with more than 60 successful drugs developed in the past 30 years. However, many of these single-kinase inhibitors show low efficacy and drug resistance has become an issue. Owing to the occurrence of highly conserved catalytic sites and shared signaling pathways within a kinase family, multi-target kinase inhibitors have attracted attention. Results To design and identify such pan-kinase family inhibitors (PKFIs), we proposed PKFI sets for eight families using 200,000 experimental bioactivity data points and applied a graph convolutional network (GCN) to build classification models. Furthermore, we identified and extracted family-sensitive (only present in a family) pre-moieties (parts of complete moieties) by utilizing a visualized explanation (i.e., where the model focuses on each input) method for deep learning, gradient-weighted class activation mapping (Grad-CAM). Conclusions This study is the first to propose the PKFI sets, and our results point out and validate the power of GCN models in understanding the pre-moieties of PKFIs within and across different kinase families. Moreover, we highlight the discoverability of family-sensitive pre-moieties in PKFI identification and drug design.https://doi.org/10.1186/s12859-022-04773-0Pan-kinase family inhibitorGraph convolutional networkVisualized explanationGradient-weighted class activation mappingFamily-sensitive pre-moiety
spellingShingle Xiang-Yu Lin
Yu-Wei Huang
You-Wei Fan
Yun-Ti Chen
Nikhil Pathak
Yen-Chao Hsu
Jinn-Moon Yang
Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties
BMC Bioinformatics
Pan-kinase family inhibitor
Graph convolutional network
Visualized explanation
Gradient-weighted class activation mapping
Family-sensitive pre-moiety
title Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties
title_full Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties
title_fullStr Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties
title_full_unstemmed Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties
title_short Identification of pan-kinase-family inhibitors using graph convolutional networks to reveal family-sensitive pre-moieties
title_sort identification of pan kinase family inhibitors using graph convolutional networks to reveal family sensitive pre moieties
topic Pan-kinase family inhibitor
Graph convolutional network
Visualized explanation
Gradient-weighted class activation mapping
Family-sensitive pre-moiety
url https://doi.org/10.1186/s12859-022-04773-0
work_keys_str_mv AT xiangyulin identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties
AT yuweihuang identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties
AT youweifan identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties
AT yuntichen identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties
AT nikhilpathak identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties
AT yenchaohsu identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties
AT jinnmoonyang identificationofpankinasefamilyinhibitorsusinggraphconvolutionalnetworkstorevealfamilysensitivepremoieties